In Singapore, researchers examining epigenetic data from more than 4,200 individuals have found that users of a delayed-release alpha-ketoglutarate supplement showed biological ages averaging 1.8 years younger than non-users — a finding that places an ancient metabolic molecule at the center of humanity's enduring search for ways to slow the passage of time within the body. The association held across demographics and persisted after accounting for lifestyle factors, yet longer-term tracking of the same individuals failed to confirm the effect with statistical confidence. Science here offers a
NutraIngredients.com
· Jul 01, 2026
· health
· 2 min de leitura
Medium
Apuração: Caracterizado
Singapore study links dAKG supplement to 1.8-year biological age reduction
◉
Science & Space
6944 artigos relacionados
NASA Launches Artemis II: Four Astronauts Head to Moon in Historic Mis…
Devdiscourse · 100% correspondência
SpaceX's upgraded Starship rocket poised for critical test flight
CBS News · 99% correspondência
NASA Revises Artemis III Plans, Complicating SpaceX's Role in 2027 Moo…
Google News · 99% correspondência
Astronaut Scott Kelly brings space exploration insights to Adelaide th…
Glam Adelaide · 99% correspondência
SpaceX Launches New Dragon Cargo Capsule to ISS With Plant-Growing Exp…
Gizmodo · 99% correspondência
Cobertura Relacionada
The Guardian · Aug 23
British firm trafficked enslaved Africans 40 years after abolition, letter reveals
Evidence reveals Sandbach, Tinne and Company illegally trafficked enslaved Africans to Guyana in 1847, four decades afte…
Space Daily · Aug 23 Webb finds Neptune's upper atmosphere far colder than Voyager measured 34 years agoWebb's 2023 observations reveal Neptune's upper atmosphere is 358K, far colder than Voyager 2's 1989 measurement of 750K…
Science Daily · Aug 23 Fast-spinning stars survive black hole encounters, revealing why their flares fadeAstronomers discovered that stars with rapid pre-existing rotation survive repeated close encounters with supermassive b…
Indian Aerospace and Defence Bulletin · Aug 23 India Charts Course for Sustainable Space Operations Amid Orbital Debris CrisisIndia launches initiatives to prevent orbital debris and establish sustainable space operations, including ISRO's Debris…
Viés e Enquadramento
⚖
Article presents promising cross-sectional findings on dAKG supplementation while downplaying contradictory longitudinal results, with potential commercial bias toward featured product.
Bias Direction
center-right
Confidence
HIGH
Selective emphasis on positive cross-sectional results in headline and opening while burying non-significant longitudinal findings; product-specific focus on commercially available Rejuvant creates implicit endorsement framing.
biological age reduction
biological age reversal (in URL)
significantly younger
lowest Age Residual
notably
Critical analysis of cross-sectional vs. longitudinal study limitations
Expert commentary on why longitudinal results contradicted cross-sectional findings
Discussion of potential confounding variables in supplement user demographics
Skeptical scientific perspective on biological age measurement validity
Disclosure of potential financial relationships between researchers and supplement manufacturers
Comparison to effect sizes of established interventions
Explanation of why non-significant longitudinal results should temper enthusiasm
Impacto Geopolítico
🌎
Singapore longevity research on dAKG supplements has minimal geopolitical significance; primarily a commercial health science development with no direct international relations implications.
Escalation Risk
low
Confidence
HIGH
No meaningful shifts. This is a nutritional science study with potential commercial benefits for Singapore's biotech/wellness sectors and the supplement industry globally.
Lente Econômica
📈
Singapore study shows dAKG supplement linked to 1.8-year biological age reduction in cross-sectional analysis, but longitudinal results were non-significant, suggesting limited causal evidence for anti-aging claims.
Market Signal
mixed
Confidence
MED
Dietary supplements and nutraceuticals
Biotechnology and longevity research
Healthcare and wellness
Pharmaceutical manufacturing
Direct-to-consumer health testing
Consumers may increase spending on dAKG and other longevity supplements based on cross-sectional findings, though non-significant longitudinal results suggest benefits may be overstated. This could drive demand for epigenetic testing services and premium supplement products, potentially increasing household health expenditures.
Regulators may scrutinize supplement marketing claims around biological age reversal and longevity benefits. FDA and similar bodies may require stronger longitudinal evidence before allowing anti-aging claims. Study methodology limitations (cross-sectional vs. longitudinal discrepancy) may prompt calls for stricter clinical trial standards in the supplement industry.